WHO ICTRP trial
Effect of neogard protection to reduce nasal injury in preterm infants receiving…
IRCT20191217045769N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20191217045769N1 |
|---|---|
| Public title | Effect of neogard protection to reduce nasal injury in preterm infants receiving N-CPAP |
| Scientific title | A comparative study on the effect of using nasal protector (Neo-Guard)on the incidence rate and severity of nasal injury in preterm infants treated with Nasal-Continuous Positive Airway Pressure |
| Primary sponsor | Esfahan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | Nasal injury associated with N-CPAP in preterm infants. Preterm [premature] newborn [other];P07.3 |
| Interventions | Intervention 1: Intervention group will use neoguard nasal protector to prevent nasal injury. Intervention 2: Control group will receive routine care. |
| Registration date | Mar 15, 2020 |
| Target size | 80 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: